Table 4 Clinical and lesion characteristics

Age,years

62 ± 11

59 ± 13

0.207

Body mass index,kg/m²

24.7 ± 3.1

23.6 ± 2.6

0.155

LDL-C,mmol/L

2.7 ± 1.1

3.0 ± 1.4

0.34

TC,mmol/L

4.1 ± 1.2

4.5 ± 1.4

0.225

HDL-C,mmol/L

1.0 ± 0.3

1.1 ± 0.3

0.514

SCr,umol/L

83.2 ± 55.5

73.2 ± 9.6

0.448

LVEF,%

63.4 ± 9.5

63.3 ± 11.2

0.965

Triglyceride,mg/L

138.3 ± 74.7

159.9 ± 79.0

0.253

Triglyceride-glucose index

8.8 ± 0.5

9.0 ± 0.6

0.058

Fasting blood glucose,mg/dL

107.7 ± 34.0

123.3 ± 37.6

0.072

Hemoglobin A1C,%

6.8 ± 1.5

7.0 ± 1.4

0.485

Reference vessel diameter,mm

2.6 ± 0.7

2.4 ± 0.6

0.371

Maximum drug-coated balloon diameter,mm

2.6 ± 0.5

2.7 ± 0.5

0.747

Maximum drug-coated pressure, atm

10.6 ± 2.6

10.6 ± 2.1

0.972

Men,n(%)

106 (76.3%)

16 (88.9%)

0.226

ACS,n(%)

117 (84.2%)

15 (83.3%)

0.927

Hypertension,n(%)

96 (69.1%)

7 (38.9%)

0.011

Diabetes mellitus,n(%)

57 (41.0%)

9 (50.0%)

0.467

Current smoker,n(%)

39 (28.1%)

8 (44.4%)

0.153

ACEI/ARB/ARNI,n(%)

81 (58.3%)

9 (50.0%)

0.504

Beta-blocker,n(%)

97 (69.8%)

14 (77.8%)

0.483

Statins,n(%)

138 (99.3%)

18 (100.0%)

0.718

Ticagrelor,n(%)

105 (75.5%)

11 (61.1%)

0.19

Clopidogrel,n(%)

33 (23.7%)

7 (38.9%)

0.165

Aspirin,n(%)

132 (95.0%)

18 (100.0%)

0.33

Type of predilation drug

0.538

Cutting balloon,n(%)

42 (30.2%)

7 (38.9%)

Semicompliant balloon,n(%)

67 (48.2%)

6 (33.3%)

Noncompliant balloon,n(%)

7 (5.0%)

2 (11.1%)

Both/All,n(%)

23 (16.5%)

3 (16.7%)

Type of target vessel

0.598

LAD,n(%)

64 (46.0%)

10 (55.6%)

LCX,n(%)

38 (27.3%)

5 (27.8%)

RCA,n(%)

25 (18.0%)

3 (16.7%)

Branch,,n(%)

12 (8.6%)

0 (0.0%)

Post-procedure TIMI grade 3 flow,n(%)

137 (98.6%)

17 (94.4%)

0.23

Drug-coated balloon diameter to vessel diameter ratio(1:1),n(%)

137 (98.6%)

17 (94.4%)

0.23